{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T02:45:46Z","timestamp":1774925146005,"version":"3.50.1"},"reference-count":21,"publisher":"XMLink","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"SK bioscience"}],"content-domain":{"domain":["icjournal.org"],"crossmark-restriction":false},"short-container-title":["Infect Chemother"],"published-print":{"date-parts":[[2026]]},"DOI":"10.3947\/ic.2025.0095","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T01:13:13Z","timestamp":1772413993000},"page":"49","update-policy":"https:\/\/doi.org\/10.3947\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-Marketing Surveillance Study of the Live Attenuated Varicella Vaccine (SKYVaricella Inj.) in Korean Children"],"prefix":"10.3947","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1815-8901","authenticated-orcid":false,"given":"Hyunjeong","family":"Kim","sequence":"first","affiliation":[{"name":"Medical Affair, SK bioscience Co., Ltd., Incheon, Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5146-4144","authenticated-orcid":false,"given":"Kihyun","family":"Kim","sequence":"additional","affiliation":[{"name":"Medical Affair, SK bioscience Co., Ltd., Incheon, Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9939-3737","authenticated-orcid":false,"given":"Hye Young","family":"Kim","sequence":"additional","affiliation":[{"name":"Medical Affair, SK bioscience Co., Ltd., Incheon, Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18617","reference":[{"key":"10.3947\/ic.2025.0095_ref1","unstructured":"StatPearls. Treasure Island, FL. StatPearls Publishing. 2025. Accessed 20 August 2025. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448191\/"},{"key":"10.3947\/ic.2025.0095_ref2","first-page":"265","volume":"89","author":"World Health Organization","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"10.3947\/ic.2025.0095_ref3","first-page":"257","volume":"64","author":"Hesham","year":"2009","journal-title":"Med J Malaysia"},{"key":"10.3947\/ic.2025.0095_ref4","first-page":"1","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"10.3947\/ic.2025.0095_ref5","unstructured":"Korea Disease Control and Prevention Agency (KDCA). Annual report on the notified infectious diseases in Korea, 2022. Cheongju. KDCA. 2023. Accessed 20 August 2025. Chapter 2, p.22. Available at: https:\/\/dportal.kdca.go.kr\/pot\/bbs\/BD_selectBbs.do?q_bbsSn=1010&q_bbsDocNo=20230908669355443&q_clsfNo=1"},{"key":"10.3947\/ic.2025.0095_ref6","unstructured":"Korea Disease Control and Prevention Agency (KDCA). Vaccine effectiveness of varicella vaccination program. Final report of policy research service project. Cheongju. KDCA. 2024. Accessed 20 August 2025. Report No.: 11-1790387-001173-01. Available at: https:\/\/library.nih.go.kr\/ncmiklib\/synap\/skin\/doc.html?fn=afed24f985000f975616a3cc9ebc74a67a2deb8fd13962707d106b8255a6bc3b&rs=\/roms\/ncmik\/st1\/synap\/202602&fileKey=254291&pn=1"},{"key":"10.3947\/ic.2025.0095_ref7","unstructured":"Korea Disease Control and Prevention Agency (KDCA). Analysis on trends of nationally notifiable infectious diseases, 2024. Accessed 20 August 2025. Available at: https:\/\/www.kdca.go.kr\/kdca\/2848\/subview.do?enc=Zm5jdDF8QEB8JTJGYmJzJTJGa2RjYSUyRjQyJTJGMjE1MzAyJTJGYXJ0Y2xWaWV3LmRvJTNGcGFzc3dvcmQlM0QlMjZyZ3NCZ25kZVN0ciUzRCUyNmZpbmRPcG53cmQlM0QlMjZmaW5kV29yZCUzRCUyNnJnc0VuZGRlU3RyJTNEJTI2ZmluZFR5cGUlM0QlMjZmaW5kQ2xTZXElM0QlMjZwYWdlJTNEMjQlMjY%3D&utm_source=chatgpt.com"},{"key":"10.3947\/ic.2025.0095_ref8","unstructured":"Korea Disease Control and Prevention Agency (KDCA). Mandatory surveillance infectious disease: Varicella (chickenpox). Accessed 20 August 2025. Available at: https:\/\/dportal.kdca.go.kr\/pot\/is\/summaryEDW.do?icdgrpCd=02&icdCd=NB0002"},{"key":"10.3947\/ic.2025.0095_ref9","doi-asserted-by":"crossref","first-page":"20420986221118972","DOI":"10.1177\/20420986221118972","volume":"13","author":"Rudolph","year":"2022","journal-title":"Ther Adv Drug Saf"},{"key":"10.3947\/ic.2025.0095_ref10","unstructured":"Korea Disease Control and Prevention Agency (KDCA). Standard immunization schedule. Cheongju. KDCA. 2024. Accessed 20 August 2025. Available at: https:\/\/nip.kdca.go.kr\/irhp\/infm\/goVcntInfo.do?menuLv=1&menuCd=115"},{"key":"10.3947\/ic.2025.0095_ref11","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s40264-020-00967-8","volume":"43","author":"Wang","year":"2020","journal-title":"Drug Saf"},{"key":"10.3947\/ic.2025.0095_ref12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02599650","volume":"9","author":"Falvo","year":"1994","journal-title":"J Gen Intern Med"},{"key":"10.3947\/ic.2025.0095_ref13","doi-asserted-by":"crossref","first-page":"e008215","DOI":"10.1136\/bmjgh-2021-008215","volume":"7","author":"Bauwens","year":"2022","journal-title":"BMJ Glob Health"},{"key":"10.3947\/ic.2025.0095_ref14","volume-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Centers for Disease Control and Prevention (CDC)","year":"2021","edition":"14"},{"key":"10.3947\/ic.2025.0095_ref15","volume-title":"Manual for the surveillance of vaccine-preventable diseases","author":"Centers for Disease Control and Prevention (CDC)","year":"2022","edition":"6"},{"key":"10.3947\/ic.2025.0095_ref16","unstructured":"Government of Canada. Varicella (chickenpox) vaccines: Canadian immunization guide. Public Health Agency of Canada. 2023. Accessed 20 August 2025. Available at: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/canadian-immunization-guide-part-4-active-vaccines\/page-24-varicella-chickenpox-vaccine.html"},{"key":"10.3947\/ic.2025.0095_ref17","unstructured":"Centers for Disease Control and Prevention (CDC). Epidemiology and prevention of vaccine-preventable diseases (The pink book). Chapter 22: Varicella. CDC. 2023. Accessed 20 August 2025. Available at: https:\/\/www.cdc.gov\/pinkbook\/hcp\/table-of-contents\/chapter-22-varicella.html?CDC_AAref_Val=https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/varicella.html"},{"issue":"Suppl 4","key":"10.3947\/ic.2025.0095_ref18","doi-asserted-by":"crossref","first-page":"S450","DOI":"10.1093\/infdis\/jiac363","volume":"226","author":"Dollard","year":"2022","journal-title":"J Infect Dis"},{"key":"10.3947\/ic.2025.0095_ref19","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/vaccines11091416","volume":"11","author":"Choi","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.3947\/ic.2025.0095_ref20","unstructured":"Medsafe. New Zealand data sheet. VARIVAX\u00ae (Varicella virus vaccine live, Oka\/Merck). Accessed 20 August 2025. Available at: https:\/\/www.medsafe.govt.nz\/profs\/datasheet\/v\/Varivaxinj.pdf"},{"key":"10.3947\/ic.2025.0095_ref21","doi-asserted-by":"crossref","first-page":"ofz295","DOI":"10.1093\/ofid\/ofz295","volume":"6","author":"Woodward","year":"2019","journal-title":"Open Forum Infect Dis"}],"container-title":["Infection & Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/icjournal.org\/pdf\/10.3947\/ic.2025.0095","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/icjournal.org\/DOIx.php?id=10.3947\/ic.2025.0095","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/icjournal.org\/DOIx.php?id=10.3947\/ic.2025.0095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T01:50:59Z","timestamp":1774921859000},"score":1,"resource":{"primary":{"URL":"https:\/\/icjournal.org\/DOIx.php?id=10.3947\/ic.2025.0095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3947\/ic.2025.0095","relation":{},"ISSN":["2093-2340","2092-6448"],"issn-type":[{"value":"2093-2340","type":"print"},{"value":"2092-6448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2025-08-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-24","name":"published_online","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 2026 by The Korean Society of Infectious Diseases, Korean Society for Antimicrobial Therapy, The Korean Society for AIDS, and Korean Society of Pediatric Infectious Diseases","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}